Literature DB >> 16887958

Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells".

Leigh A Stephens, Stephen M Anderton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16887958     DOI： 10.4049/jimmunol.177.4.2036

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  18 in total

Review 1.  Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Authors:  Ronit Mazor; Emily M King; Masanori Onda; Nicolas Cuburu; Selamawit Addissie; Devorah Crown; Xiu-Fen Liu; Takashi Kei Kishimoto; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.

Authors:  Ribal Bassil; Bing Zhu; Youmna Lahoud; Leonardo V Riella; Hideo Yagita; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

3.  Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.

Authors:  William H D Hallett; Erik Ames; Maite Álvarez; Isabel Barao; Patricia A Taylor; Bruce R Blazar; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

4.  Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

Authors:  David C Gondek; Victor Devries; Elizabeth C Nowak; Li-Fan Lu; Kathryn A Bennett; Zachary A Scott; Randolph J Noelle
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.

Authors:  E Brisse; M Imbrechts; T Mitera; J Vandenhaute; N Berghmans; L Boon; C Wouters; R Snoeck; G Andrei; P Matthys
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

6.  Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.

Authors:  Kevin N Couper; Daniel G Blount; J Brian de Souza; Isabelle Suffia; Yasmine Belkaid; Eleanor M Riley
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.

Authors:  David J Huss; Alex F Pellerin; Brian P Collette; Arun K Kannan; Liaomin Peng; Abhishek Datta; Brian T Wipke; Jason D Fontenot
Journal:  Immunology       Date:  2016-05-12       Impact factor: 7.397

8.  STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation.

Authors:  Nicolas J Dorsey; Svetlana P Chapoval; Elizabeth P Smith; Jonathan Skupsky; David W Scott; Achsah D Keegan
Journal:  J Immunol       Date:  2013-07-03       Impact factor: 5.422

9.  A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma.

Authors:  Marie-Denise Poirier; Houda Haban; Abdeljabar El Andaloussi
Journal:  J Oncol       Date:  2010-03-21       Impact factor: 4.375

10.  Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi.

Authors:  J Nihei; F Cardillo; W L C Dos Santos; L Pontes-de-Carvalho; J Mengel
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.